Table 3.
Classifications
| Variables, n (%) | n = 1630 |
|---|---|
| Gender, male | 843 (51.7) |
| Female | 787 (48.3) |
| Age group | |
| ≤ 19 | 1 (0.1) |
| 20–29 | 42 (2.6) |
| 30–39 | 223 (13.7) |
| 40–49 | 615 (37.7) |
| 50–59 | 417 (25.6) |
| 60–69 | 246 (15.1) |
| 70–79 | 81 (5.0) |
| ≥ 80 | 5 (0.3) |
| CKD stage | |
| G1 | 62 (3.8) |
| G2 | 299 (18.3) |
| G3a | 328 (20.1) |
| G3b | 440 (27.0) |
| G4 | 490 (30.1) |
| G5 | 9 (0.6) |
| Unknown | 2 (0.1) |
| Total kidney volume | |
| < 750 mL | 4 (0.2) |
| ≥ 750– < 1500 mL | 369 (22.6) |
| ≥ 1500– < 3000 mL | 403 (24.7) |
| ≥ 3000– < 4500 mL | 139 (8.5) |
| ≥ 4500– < 6000 mL | 31 (1.9) |
| ≥ 6000 mL | 19 (1.2) |
| Missing or before Day -90 | 665 (40.8) |
| Mayo classification | |
| 1A | 0 (0.0) |
| 1B | 152 (9.3) |
| 1C | 317 (19.4) |
| 1D | 242 (14.8) |
| 1E | 90 (5.5) |
| Missing | 829 (50.9) |
CKD chronic kidney disease, SD standard deviation
Baseline value is defined as the last available value on or prior to the first dose date
CKD stages were based on eGFR value (mL/min/1.73 m2): G1 (≥ 90), G2 (60 to 89), G3a (45 to 59), G3b (30 to 44), G4 (15 to 29), and G5 (< 15)
The baseline values for TKV and eGFR are defined as the last available values, on or prior to the first dose, extending back to Day -90